Indium (111In) biciromab
From WikiMD's WELLNESSPEDIA
(Redirected from FibriScint)
| Indium (111In) biciromab
| |
|---|---|
| Trade names | FibriScint
|
| Pregnancy category | N/A
|
| Legal status | Withdrawn |
| Identifiers | |
| CAS Number | 138783-13-8
|
| ChemSpider | none
|
| KEGG | D03111
|
Indium (111In) biciromab (INN, trade name FibriScint, developed by Centocor) was a drug targeting fibrin, a protein involved in the clotting of blood.[1] It was the Fab' fragment of a mouse monoclonal antibody labelled with the radioisotope indium-111 for the diagnosis of thromboembolism,[2] but was withdrawn during clinical trials.[3]
References[edit]
- ↑ King, David J.."Recombinant antibodies for the diagnosis and therapy of human disease".Current Opinion in Drug Discovery & Development.1999;2(2)
- 112.
- ↑ Answers.com: Centocor Ortho Biotech Products, L.P.
- ↑ DiagnosticImaging.com: Centocor withdraws imaging agent applications
| Monoclonals for bone, musculoskeletal, circulatory, and neurologic systems | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|